Evaluating the Efficacy of Intravenous Acetaminophen (IV Tylenol) in Reducing Pain and Agitation in Pediatric Patients Undergoing Elective Tonsillectomy and/or Adenoidectomy

N/AEnrolling By InvitationNCT07576985

MetroHealth Medical Center20 enrolled

Overview

MetroHealth's main campus administers IV Tylenol as part of its pain management protocol for elective tonsillectomy/adenoidectomy, whereas Parma campus does not. Comparing these practices provides an opportunity to evaluate the benefits of IV Tylenol for pain, agitation, and associated secondary outcomes in this population. The pain/agitation would be assessed with a validated tool PAED and FLACC

Study Type

OBSERVATIONAL

Enrollment

Conditions

Tonsillectomy Adenoidectomy

Interventions

No Intervention: Observational CohortOTHER

No Intervention: Observational Cohort

Eligibility

Sex: ALLMax age: 8 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects pediatric patients aged ≤7 years, observed by study team who will complete the scales * Undergoing elective tonsillectomy and adenoidectomy. Exclusion Criteria: * Pre-existing neurological or developmental disorders impacting pain/agitation scores

Outcomes

Primary Outcomes

Pain Assessment

Evaluate the impact of IV Acetaminophen on pain at emergence and in the Post-Anesthesia Care Unit (PACU) using a validated pediatric assessment tool, FLACC (Face, Legs, Activity, Cry, Consolable) Behavior Pain Assessment Tool.

Time frame: * "Baseline" * "Perioperative/Periprocedural"

Secondary Outcomes

Agitation Assessment

Evaluate the impact of IV Tylenol on Agitation scores at emergence and in the Post-Anesthesia Care Unit (PACU) using a validated pediatric assessment tool, Pediatric Anesthesia Emergence Delirium (PAED) scale.